[This Week's IPO] Bookbuilding and Subscription Schedule for the Fourth Week of November View original image

In the fourth week of November, Inovot Therapeutics and Mothers Pharmaceutical will conduct bookbuilding for institutional investors. KMF and ANH Structure are preparing for their public offerings.


<Bookbuilding>


◆Inovot Therapeutics= Founded in 2019, Inovot Therapeutics is a company that researches and develops synthetic drugs for immune and inflammatory diseases, fibrosis, and cancer using DeepZema®, its artificial intelligence (AI)-based drug discovery platform. It has built a pipeline across various therapeutic areas based on its in-house drug development capabilities, and has demonstrated its technological competitiveness and commercialization potential through clinical development results and technology transfer deals.


The total offering will comprise 2.2 million shares, with an indicative price range of KRW 20,000 to KRW 24,000 per share. Based on this range, the total offering is expected to raise approximately KRW 44 billion to KRW 52.8 billion. The company will conduct bookbuilding for institutional investors from November 26 to December 2 to set the final offer price, followed by a public subscription on December 7 and 8. It plans to list on the KOSDAQ market. Korea Investment & Securities is the lead underwriter.


◆Mothers Pharmaceutical= Founded in 2011, Mothers Pharmaceutical operates businesses centered on the development, production, and sale of ▲prescription drugs (ETC), as well as ▲over-the-counter drugs (OTC), ▲contract manufacturing of pharmaceuticals (CMO), and ▲drug development. CEO Kim Jwajin, a former pharmacist, has applied his understanding of the market and prescribing practices, gained through running a pharmacy and working in pharmaceutical distribution, to the company's product development strategy.


The offering will comprise 2.4 million shares. The indicative price range is KRW 11,000 to KRW 14,500 per share, putting the expected total offering at KRW 26.4 billion to KRW 34.8 billion. Bookbuilding for institutional investors is scheduled for November 27 to December 3, followed by a public subscription on December 8 and 9. The company's expected market capitalization after listing is approximately KRW 163.2 billion to KRW 215.1 billion, based on the indicative price range. It aims to list on the KOSDAQ market in December. KB Securities and NH Investment & Securities are the underwriters.


<Public Subscription>


◆KMF= The indicative price range is KRW 15,000 to KRW 17,800 per share. The total offering is expected to raise KRW 30 billion to KRW 35.6 billion. The company completed bookbuilding for institutional investors on November 20 and plans to list on the KOSDAQ market after its public subscription on November 24 and 25. IBK Investment & Securities is the lead underwriter.


KMF is a venture company founded by a Keimyung University professor. Since its establishment in 2002, it has developed and produced functional foods and biomaterials based on fermentation and enzyme technologies. Starting with the development of materials such as low-molecular-weight proteins, enzyme-based foods, and kombucha ingredients, the company has led their commercialization into products, driving sales from major clients.


◆ANH Structure= The indicative price range is KRW 11,200 to KRW 13,600 per share, with the offering expected to raise approximately KRW 23.5 billion to KRW 28.6 billion. The company is scheduled to conduct bookbuilding for institutional investors through November 25, followed by a public subscription from November 27 to 30, and aims to list on the KOSDAQ market by the end of the year. NH Investment & Securities is the lead underwriter.



Since its establishment in 2013, ANH Structure has expanded its business based on aircraft structural design and composite materials manufacturing technologies. It has begun to secure sustained growth drivers through a "two-track" strategy encompassing defense, centered on unmanned aerial vehicles, and the commercial aviation business, centered on cabin solutions. It is also expanding its pipeline to include the commercialization of space launch vehicles and small satellites.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing